Predictive value of tumor genetic alteration profiling for chemotherapy and EGFR-TKI treatment in advanced NSCLC

Previous studies have suggested that a variety of tumor driver genetic alterations affected the treatment efficacy of chemotherapy and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in advanced non-small cell lung cancer (NSCLC). The present study aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wei, Zeng, Aiping, Ning, Ruiling, Zhao, Wenhua, Su, Cuiyun, Wang, Huilin, Zhou, Shaozhang, Yu, Qitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202306/
https://www.ncbi.nlm.nih.gov/pubmed/32382334
http://dx.doi.org/10.3892/ol.2020.11502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202306/
https://www.ncbi.nlm.nih.gov/pubmed/32382334
http://dx.doi.org/10.3892/ol.2020.11502

Ejemplares similares